Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : XENE source : Www.biospace.com save search
Xenon Forging Ahead in MDD Despite Mid-stage Flop
Published: 2023-11-27 (Crawled : 21:00) - biospace.com/
XENE | $39.91 -0.99% -1.0% 360K
|
Health Technology
|
| O: 0.1%
H: 18.14%
C: 17.66%
Xenon Pharmaceuticals Showcases Its XEN1101 Epilepsy Program at the 2023 American Academy of Neurology (AAN) Annual Meeting
Published: 2023-04-24 (Crawled : 12:20) - biospace.com/
XENE | $39.91 -0.99% -1.0% 360K
|
Health Technology
|
| O: 0.61%
H: 0.93%
C: -0.93%
xen1101 pharmaceuticals meeting program
Xenon Pharmaceuticals to Present at the Stifel 2023 CNS Days
Published: 2023-03-22 (Crawled : 23:00) - biospace.com/
XENE | $39.91 -0.99% -1.0% 360K
|
Health Technology
|
| O: -0.15%
H: 1.68%
C: 0.42%
pharmaceuticals
Xenon Pharmaceuticals to Present at the SVB Securities Global Biopharma Conference
Published: 2023-02-08 (Crawled : 23:00) - biospace.com/
XENE | $39.91 -0.99% -1.0% 360K
|
Health Technology
|
| O: -0.33%
H: 1.04%
C: -1.6%
biopharma pharmaceuticals global conference
Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2023
Published: 2023-01-09 (Crawled : 18:00) - biospace.com/
XENE | $39.91 -0.99% -1.0% 360K
|
Health Technology
|
| O: 0.29%
H: 0.0%
C: -3.73%
pharmaceuticals milestone
Xenon Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference
Published: 2023-01-04 (Crawled : 23:00) - biospace.com/
XENE | $39.91 -0.99% -1.0% 360K
|
Health Technology
|
| O: 1.8%
H: 1.08%
C: -0.47%
pharmaceuticals conference
Former Merck Commercial President Dawn Svoronos joins ACELYRIN, INC. Board of Directors
Published: 2022-12-13 (Crawled : 14:00) - biospace.com/
XENE | $39.91 -0.99% -1.0% 360K
|
Health Technology
|
| O: 1.36%
H: 0.39%
C: -1.65%
THTX | $1.29 -12.78% 8.1K
|
Health Technology
|
| O: 0.0%
H: 5.0%
C: 3.0%
commercial
Xenon Pharmaceuticals to Present at the Bank of America Securities Biotech SMID Cap Conference 2022
Published: 2022-11-30 (Crawled : 22:00) - biospace.com/
XENE | $39.91 -0.99% -1.0% 360K
|
Health Technology
|
| O: -0.11%
H: 3.0%
C: 1.46%
america pharmaceuticals conference biotech
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter 2022 Financial Results and Provide Corporate Update
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
XENE | $39.91 -0.99% -1.0% 360K
|
Health Technology
|
| O: 1.18%
H: 4.35%
C: 0.32%
pharmaceuticals conference financial update results
Xenon Pharmaceuticals to Present at the Wells Fargo 2022 Healthcare Conference
Published: 2022-09-01 (Crawled : 21:00) - biospace.com/
XENE | $39.91 -0.99% -1.0% 360K
|
Health Technology
|
| O: -0.7%
H: 3.27%
C: 2.57%
conference
Xenon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-08-09 (Crawled : 23:00) - biospace.com/
XENE | $39.91 -0.99% -1.0% 360K
|
Health Technology
|
| O: -0.13%
H: 1.24%
C: -0.63%
PCRX | $26.24 0.54% 0.53% 450K
|
Health Technology
|
| O: 0.22%
H: 0.29%
C: -0.55%
update results
Xenon Pharmaceuticals to Present at the 13th Annual Wedbush PacGrow Healthcare Conference
Published: 2022-08-08 (Crawled : 13:00) - biospace.com/
XENE | $39.91 -0.99% -1.0% 360K
|
Health Technology
|
| O: 0.83%
H: 4.0%
C: 2.22%
conference
Xenon Pharmaceuticals to Present at the William Blair Biotech Focus Conference 2022
Published: 2022-07-11 (Crawled : 21:00) - biospace.com/
XENE | $39.91 -0.99% -1.0% 360K
|
Health Technology
|
| O: -0.27%
H: 2.43%
C: -0.78%
conference biotech
Xenon Pharmaceuticals Provides Update on Additional Positive Data from the XEN1101 Program
Published: 2022-06-22 (Crawled : 21:00) - biospace.com/
XENE | $39.91 -0.99% -1.0% 360K
|
Health Technology
|
| O: 7.12%
H: 0.0%
C: 0.0%
xen1101 program positive update
Xenon Pharmaceuticals Announces Positive Outcome of End-of-Phase 2 Meeting with the FDA
Published: 2022-06-21 (Crawled : 12:20) - biospace.com/
XENE | $39.91 -0.99% -1.0% 360K
|
Health Technology
|
| O: 8.06%
H: 0.0%
C: 0.0%
fda meeting positive phase 2
Xenon Pharmaceuticals to Present at the 2022 Jefferies Healthcare Conference
Published: 2022-06-01 (Crawled : 22:00) - biospace.com/
XENE | $39.91 -0.99% -1.0% 360K
|
Health Technology
|
| O: 0.57%
H: 1.81%
C: 0.68%
conference
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2022 Financial Results and Provide Corporate Update
Published: 2022-05-03 (Crawled : 00:00) - biospace.com/
XENE | $39.91 -0.99% -1.0% 360K
|
Health Technology
|
| O: -0.22%
H: 0.0%
C: 0.0%
conference results
Xenon Pharmaceuticals Announces Initiation of Phase 2 Clinical Trial to Evaluate XEN1101 as a Treatment for Major Depressive Disorder (MDD)
Published: 2022-05-03 (Crawled : 19:00) - biospace.com/
XENE | $39.91 -0.99% -1.0% 360K
|
Health Technology
|
| O: -0.22%
H: 0.0%
C: 0.0%
xen1101 treatment trial phase 2 major depressive disorder
Xenon Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference
Published: 2022-04-04 (Crawled : 22:00) - biospace.com/
XENE | $39.91 -0.99% -1.0% 360K
|
Health Technology
|
| O: 1.11%
H: 4.55%
C: 4.37%
conference
Xenon Pharmaceuticals to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
Published: 2022-02-14 (Crawled : 23:00) - biospace.com/
XENE | $39.91 -0.99% -1.0% 360K
|
Health Technology
|
| O: 0.72%
H: 1.88%
C: -0.58%
health als thc conference svb leerink global
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.